tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cingulate price target lowered to $11 from $12 at Roth Capital
PremiumThe FlyCingulate price target lowered to $11 from $12 at Roth Capital
2M ago
Cingulate, Inc. Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Cingulate, Inc. Reports Increased Losses Amid R&D Expansion
2M ago
Cingulate receives formal pre-NDA meeting minutes from FDA for CTx-1301
Premium
The Fly
Cingulate receives formal pre-NDA meeting minutes from FDA for CTx-1301
2M ago
Cingulate receives $3M grant from to accelerate development of CTx-2103
PremiumThe FlyCingulate receives $3M grant from to accelerate development of CTx-2103
3M ago
Cingulate Inc’s Strategic Progress and Promising Clinical Results Justify Buy Rating
Premium
Ratings
Cingulate Inc’s Strategic Progress and Promising Clinical Results Justify Buy Rating
4M ago
Cingulate completes pre-NDA meeting with FDA on NDA for CTx-1301
Premium
The Fly
Cingulate completes pre-NDA meeting with FDA on NDA for CTx-1301
4M ago
Cingulate Inc. Advances Towards FDA Approval for CTx-1301
PremiumCompany AnnouncementsCingulate Inc. Advances Towards FDA Approval for CTx-1301
5M ago
Cingulate reports safety results from final Phase 3 trials for CTx-1301
Premium
The Fly
Cingulate reports safety results from final Phase 3 trials for CTx-1301
5M ago
Cingulate price target adjusted to $20 from $8 at H.C. Wainwright
Premium
The Fly
Cingulate price target adjusted to $20 from $8 at H.C. Wainwright
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100